by Eric Christianson | Mar 9, 2014 | Cardiovascular Medication and Disease State Clinical Pearls, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
88 y/o with a history of depressive type symptoms was placed on an antidepressant to manage symptoms shortly after admission to a long term care facility. This particular patient was trialed on Zoloft (sertraline) and then transitioned to Cymbalta (duloxetine),...
by Eric Christianson | Feb 9, 2014 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
A patient’s A1C was chronically high at around 9.0 with poor diet compliance. They were already reciving a fairly high dose of a sulfonylurea (glipizide) – remember that sulfonylureas stimulate the release of insulin. They were also on metformin 1000 mg...
by Eric Christianson | Nov 30, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I’m going to cover sulfonylureas tonight; this class is a mainstay in the treatment Type 2 diabetes. Other than metformin, these drugs are probably the most frequent oral class used. The most frequent names that come to mind are glipizide, glimepiride, and...
by Eric Christianson | Nov 29, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Today, it’s the DDP-4 inhibitors! DPP-4 inhibitors can be expensive which may limit their use from time to time. These drugs work to increase the amount of incretin in the body. You can look back at my post on Byetta/Victoza which should be under the diabetes...
by Eric Christianson | Nov 27, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I’m going to flip back to oral diabetes meds to cover a new agent that has recently been approved. It is a new class of diabetes med, but generally means it’s going to be quite expensive. This drug is Invokana (canagliflozin). It basically lowers glucose by causing an...
by Eric Christianson | Nov 26, 2013 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Thanks to Sarah Taylor, Pharm.D. for her guest post tonight! Sliding scale insulin, or SSI, is commonly seen in nursing homes, however, it might suprise most healthcare workers to hear that this form of diabetes “management” is not considered best...
